BCL2 and neoplasm: Conversely, the luminal B subtype (HER2+ and ER + ) showed higher expression of the luminal cluster of genes, including GATA3, BCL2 and ESR1. Therefore, a larger proportion of these tumours are driven by the ER pathways with a limited impact of HER2 oncogenic signalling pathways [70].